Physicochemical and Antibacterial Properties of PEGylated Zinc Oxide Nanoparticles Dispersed in Peritoneal Dialysis Fluid

Abstract

Owing to the peculiar broad-spectrum antimicrobial activities of zinc oxide nanoparticles (ZnO NPs), we envisaged their use to treat bacterial/mycobacterial/fungal infections during peritoneal dialysis (PD) of end-stage renal failure patients. However, a recent study from our lab showed that ZnO-NPs cannot be employed for the same in their naked form owing to their rapid agglomeration. Also, the naked ZnO-NPs showed strong interaction with organic acids present in the PD fluid (i.e., lactate and citrate present abundantly in almost all biological fluids) resulting in the formation of bioconjugates. Here, we propose that the surface coating of ZnO NPs may inhibit the binding interactions of NPs with the constituents of PD fluid. Therefore, in this study, we have carried out the surface coating of ZnO NPs with polyethylene glycol (PEG) of different molecular weights, followed by the investigations of physicochemical properties of PEGylated ZnO NPs dispersed in PD fluid using nuclear magnetic resonance (NMR) spectroscopy, dynamic light scattering (DLS), transmission electron microscopy (TEM), and Fourier transform infrared (FT-IR) spectroscopy. The interaction of PEGylated ZnO NPs has also been studied separately in glucose and lactic acid which are the main constituents of PD fluid and in citric acid. Although the X-ray diffraction and TEM results infer the colloidal stability of PEGylated ZnO NPs in PD fluid, FT-IR, UV–vis, and nuclear magnetic resonance results revealed the binding interactions of PEGylated ZnO NPs with the PD constituents. PEGylated ZnO NPs also interact strongly with the lactic acid and citric acid, leading to agglomeration, as observed previously for uncoated ZnO NPs. Further, the antibacterial activities of bare and PEG-coated ZnO NPs dispersion in PD fluid have been studied. A reduction in the bacterial inhibition effect against Staphylococcus aureus and Escherichia coli was observed for both the bare and PEG-coated ZnO NPs dispersed in PD fluid, indicating that the complex nature of PD fluid counteract on the efficiency of these nanobiotics.

Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects

“…It was previously reported that surface coating of ZnONps could prevent their interactions with biological fluid. However, Pranjali et al (2019) found that PEGylated ZnONps strongly bind and interact with peritoneal dialysis (PD) fluid, lactic and citric acids leading to agglomeration. In addition, a drastic decrease in the bacterial inhibition effect was observed for both the ZnONps and the PEG-coated ZnONps dispersed in biological fluid.…”

Nanoparticles as Anti-Microbial, Anti-Inflammatory, and Remineralizing Agents in Oral Care Cosmetics: A Review of the Current Situation

“…Anti-bacterial effects on Gram-negative and Gram-positive bacteria have been demonstrated in vitro [142,145,146]. More recently, it was shown that polyethylenglycol-encapsulated ZnO interacts strongly with the citric acid and lactic acid, leading to a bacterial inhibition effect against S. aureus and E. coli [142,154], and S. mutans and Lactobacillus in dental plaque [155]. The anti-microbial effects of ZnO are similar to Ag NPs because the smaller the NPs are, the larger the surface area becomes.…”

Biomaterials against Bone Infection

“…One of the most commonly used approaches consists of grafting PEG polymer onto the surface to create an anti-infection effect. [74] Although PEG coating itself has no bactericidal nature, its intrinsic nonfouling features decrease the bacterial interaction with its surfaces. Different approaches can be followed in order to attach different hydrophilic polymers to the biomaterials surfaces, either physical or chemical modification has been used as covalent grafting or plasma polymerization as more representative.…”